Below are the meetings where GIRO will be presented and where networking opportunities can support the initiative.
- Radiotherapy is standard of care for cervical cancer, but major global gaps in access exist, particularly in low-income and middle-income countries. The Global Task Force on Radiotherapy for Cancer Control investment framework has been used to model the health and economic benefits of scaling up external-beam radiotherapy and brachytherapy for cervical cancer in upper-middle-income, lower-middle-income, and low-income countries between 2015 and 2035. Read the recently published paper “Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact”
- The GIRO platform launched its first initiative: a survey on international patterns of care in radiation oncology. The survey aims to evaluate the use of hypofractionated radiotherapy in the treatment of breast cancer, prostate cancer, cervical cancer and bone metastases. Considering the scope of the survey and the data-driven approach, the GIRO steering committee is proud to have this survey sent under the umbrella of GIRO, ensuring coverage of all regions of the world. The survey is targeted Asia, Latin America, Africa and the Middle East in, and Europe. Data are now been analyised and a publication will be ready soon.
ESTRO meets Asia 2019
Toronto Global Cancer Control
World Cancer Congress
Kuala Lumpur, Malaysia
ESTRO meets Asia 2018
April 20th – 24th | Barcelona, Spain
Sunday, May 7th | 11:40 – 12:10 | Presidential Symposium
Sunday, May 7th | 16:30 – 17:30 | GTFRCC Symposium